Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week…

Overview of attention for article published in Cardiovascular Diabetology, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 22 X users

patent: 1 patent

Citations

dimensions_citation: 98 Dimensions

Readers on

mendeley: 117 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

SGLT-2 INHIBITOR FOR USE IN THE TREATMENT OF A METABOLIC MYOPATHY

Grant EP-3362055-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.